MannKind

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.

About MNKD

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.

CEO

Michael E. Castagna

CEOMichael E. Castagna

Employees

407

Employees407

Headquarters

Danbury, Connecticut

HeadquartersDanbury, Connecticut

Founded

1991

Founded1991

Employees

407

Employees407

MNKD Key Statistics

Market cap

1.65B

Market cap1.65B

Price-Earnings ratio

50.96

Price-Earnings ratio50.96

Dividend yield

—

Dividend yield—

Average volume

7.60M

Average volume7.60M

High today

$5.77

High today$5.77

Low today

$5.29

Low today$5.29

Open price

$5.58

Open price$5.58

Volume

6.17M

Volume6.17M

52 Week high

$7.63

52 Week high$7.63

52 Week low

$3.38

52 Week low$3.38

MNKD News

Simply Wall St 7d

MannKind Pipeline Expansion: Assessing Valuation After New United Therapeutics Collaboration

If you have been watching MannKind (MNKD), the company just shook things up. MannKind announced it is expanding its global license and collaboration agreement w...

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own MNKD. This list is generated using Robinhood data, and it’s not a recommendation.